Details for New Drug Application (NDA): 021041
✉ Email this page to a colleague
The generic ingredient in DEPOCYT is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 021041
Tradename: | DEPOCYT |
Applicant: | Pacira Pharms Inc |
Ingredient: | cytarabine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021041
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, LIPOSOMAL;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Apr 1, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 021041
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription